17β-HSD Ligand

(±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms.

(±)-Naproxen-d₃ ((Rac)-Naproxen-d₃) is the deuterated-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms.

(±)-Naproxen-d₃-1 ((Rac)-Naproxen D3 (α-methyl-d₃)) is the deuterated-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms.

(±)-Naproxen (Standard) ((Rac)-Naproxen (Standard)) is the analytical standard of (±)-Naproxen (HY-15029). This product is intended for research and analytical applications. (±)-Naproxen is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms.

HSD17B13-IN-106 is an HSD17B13 inhibitor with an IC₅₀ of 14 nM against hHSD17B13. HSD17B13-IN-106 also serves as a target protein ligand for the synthesis of HSD17B13 PROTAC degraders, such as PTOTAC HSD17B13 degrader 1 (HY-159651). HSD17B13-IN-106 can be used for research on liver diseases.

(±)-Naproxen-¹³C,d₃ ((Rac)-Naproxen-¹³C,d₃) is the ¹³C, deuterated-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms.

(±)-Naproxen-¹³C,d₃-1 ((Rac)-Naproxen-¹³C,d₃-1) is the deuterated, ¹³C-labeled (±)-Naproxen (HY-15029). (±)-Naproxen ((Rac)-Naproxen) is the racemate of Naproxen (HY-15030), consisting of R- and S-enantiomers. (±)-Naproxen binds to AKR1C3, which preferentially recognizes the R-enantiomer from the racemic mixture. It is used for AKR1C3 stereoselective ligand recognition and studies on NSAID binding mechanisms.